News
-
EP PerMed Strengthens International Collaboration Through In-situ Visit to South Africa
From 19 to 23 October 2026, EP PerMed representatives visited Cape Town, South Africa, to explore the country’s growing personalised medicine ecosystem and exchange experiences with local researchers, innovators and funding organisations. Hosted by the South African Medical Research Council (SAMRC), the visit coincided with celebrations marking ten years of precision medicine initiatives in South Africa.
-
New EP PerMed Publication Highlights Five Priorities for Implementing Personalised Medicine in Healthcare
How can personalised medicine move from scientific innovation into routine clinical practice? A new publication by EP PerMed representatives in the European Medical Specialist Review identifies five key areas for action and highlights the importance of multistakeholder collaboration to advance implementation across European healthcare systems.
-
White Paper Explores Healthcare-Specific Considerations for Artificial Intelligence
The International Organization for Standardization (ISO) has published a new white paper examining how the specific characteristics of healthcare influence the development, evaluation and implementation of artificial intelligence (AI). The report provides valuable insights for researchers and innovators working on AI-driven solutions in personalised medicine.
-
New Horizon Europe Call: Personalised Approaches to Reduce Adverse Drug Reactions
A new Horizon Europe call provides €38 million to support research into personalised approaches to improve medication safety and reduce adverse drug reactions in patients taking multiple medications. The call focuses on pharmacogenomics, biomarkers and digital technologies to enable safer, more effective and personalised treatment strategies.
EP PerMed JTC2027
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
The EP PerMed Joint Transnational Call 2027 ‘Cell and Gene Therapy for Personalised Medicine’ (CGT4PM2027) aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine.
EP PerMed Stakeholder Forum
Join to move personalised medicine forward!
The EP PerMed Stakeholder Forum brings together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine (PM) on a single platform to accelerate the translation of research findings into clinical practice and marketable applications.
Showcase your own expertise and interests in personalised medicine, either scientifically or along the value chain for implementation. Find others with exactly the knowledge you need for your next steps or be found by others, who specifically need your advice. You can reach out to potentially interesting partners directly within the platform to initiate a first contact.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.